0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nausea And Vomiting Treatment Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-32P7025
Home | Market Reports | Health| Reproductive Health
China Nausea And Vomiting Treatment Market Report Forecast 2021 2027
BUY CHAPTERS

Global Nausea And Vomiting Treatment Market Research Report 2024

Code: QYRE-Auto-32P7025
Report
January 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nausea And Vomiting Treatment Market Size

The global Nausea And Vomiting Treatment market was valued at US$ 5195.5 million in 2023 and is anticipated to reach US$ 8115.6 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Nausea And Vomiting Treatment Market

Nausea And Vomiting Treatment Market

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
This report aims to provide a comprehensive presentation of the global market for Nausea And Vomiting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nausea And Vomiting Treatment.

Report Scope

The Nausea And Vomiting Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nausea And Vomiting Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nausea And Vomiting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nausea And Vomiting Treatment Market Report

Report Metric Details
Report Name Nausea And Vomiting Treatment Market
Accounted market size in 2023 US$ 5195.5 million
Forecasted market size in 2030 US$ 8115.6 million
CAGR 6.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Segment by Application
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nausea And Vomiting Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nausea And Vomiting Treatment Market growing?

Ans: The Nausea And Vomiting Treatment Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Nausea And Vomiting Treatment Market size in 2030?

Ans: The Nausea And Vomiting Treatment Market size in 2030 will be US$ 8115.6 million.

What is the Nausea And Vomiting Treatment Market share by region?

Ans: United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.

Who are the main players in the Nausea And Vomiting Treatment Market report?

Ans: The main players in the Nausea And Vomiting Treatment Market are Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Pharmanovia, Mylan, Duchesnay, GSK

What are the Application segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Applications covered in the Nausea And Vomiting Treatment Market report are CINV, PONV, Motion Sickness, Pregnancy, Others

What are the Type segmentation covered in the Nausea And Vomiting Treatment Market report?

Ans: The Types covered in the Nausea And Vomiting Treatment Market report are Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nausea And Vomiting Treatment Market Perspective (2019-2030)
2.2 Nausea And Vomiting Treatment Growth Trends by Region
2.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nausea And Vomiting Treatment Market Dynamics
2.3.1 Nausea And Vomiting Treatment Industry Trends
2.3.2 Nausea And Vomiting Treatment Market Drivers
2.3.3 Nausea And Vomiting Treatment Market Challenges
2.3.4 Nausea And Vomiting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Revenue
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2019-2024)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue
3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2023
3.5 Nausea And Vomiting Treatment Key Players Head office and Area Served
3.6 Key Players Nausea And Vomiting Treatment Product Solution and Service
3.7 Date of Enter into Nausea And Vomiting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nausea And Vomiting Treatment Breakdown Data by Type
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030)
5 Nausea And Vomiting Treatment Breakdown Data by Application
5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2019-2030)
6.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
6.4 North America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2019-2030)
7.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024)
7.4 Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2019-2030)
8.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size (2019-2030)
9.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
9.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2019-2030)
10.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Detail
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.1.5 Merck & Co. Inc. Recent Development
11.2 Helsinn Group
11.2.1 Helsinn Group Company Detail
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.2.5 Helsinn Group Recent Development
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Detail
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.4.5 Kyowa Kirin Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Detail
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.6.5 Qilu Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Taiji group
11.8.1 Taiji group Company Detail
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.8.5 Taiji group Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Detail
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.10.5 Heron Therapeutics Recent Development
11.11 Pharmanovia
11.11.1 Pharmanovia Company Detail
11.11.2 Pharmanovia Business Overview
11.11.3 Pharmanovia Nausea And Vomiting Treatment Introduction
11.11.4 Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.11.5 Pharmanovia Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.12.5 Mylan Recent Development
11.13 Duchesnay
11.13.1 Duchesnay Company Detail
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.13.5 Duchesnay Recent Development
11.14 GSK
11.14.1 GSK Company Detail
11.14.2 GSK Business Overview
11.14.3 GSK Nausea And Vomiting Treatment Introduction
11.14.4 GSK Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.14.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Serotonin Receptor Antagonist
    Table 3. Key Players of Neurokinin NK1 Receptor Antagonist
    Table 4. Key Players of Others
    Table 5. Global Nausea And Vomiting Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Nausea And Vomiting Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Nausea And Vomiting Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Nausea And Vomiting Treatment Market Share by Region (2019-2024)
    Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Nausea And Vomiting Treatment Market Share by Region (2025-2030)
    Table 11. Nausea And Vomiting Treatment Market Trends
    Table 12. Nausea And Vomiting Treatment Market Drivers
    Table 13. Nausea And Vomiting Treatment Market Challenges
    Table 14. Nausea And Vomiting Treatment Market Restraints
    Table 15. Global Nausea And Vomiting Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Nausea And Vomiting Treatment Market Share by Players (2019-2024)
    Table 17. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2023)
    Table 18. Ranking of Global Top Nausea And Vomiting Treatment Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Nausea And Vomiting Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Nausea And Vomiting Treatment Product Solution and Service
    Table 22. Date of Enter into Nausea And Vomiting Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Nausea And Vomiting Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Nausea And Vomiting Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2019-2024)
    Table 30. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2025-2030)
    Table 32. North America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Merck & Co. Inc. Company Detail
    Table 48. Merck & Co. Inc. Business Overview
    Table 49. Merck & Co. Inc. Nausea And Vomiting Treatment Product
    Table 50. Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 51. Merck & Co. Inc. Recent Development
    Table 52. Helsinn Group Company Detail
    Table 53. Helsinn Group Business Overview
    Table 54. Helsinn Group Nausea And Vomiting Treatment Product
    Table 55. Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 56. Helsinn Group Recent Development
    Table 57. Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
    Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
    Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product
    Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 61. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
    Table 62. Kyowa Kirin Company Detail
    Table 63. Kyowa Kirin Business Overview
    Table 64. Kyowa Kirin Nausea And Vomiting Treatment Product
    Table 65. Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 66. Kyowa Kirin Recent Development
    Table 67. Sanofi Company Detail
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Nausea And Vomiting Treatment Product
    Table 70. Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. Qilu Pharma Company Detail
    Table 73. Qilu Pharma Business Overview
    Table 74. Qilu Pharma Nausea And Vomiting Treatment Product
    Table 75. Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 76. Qilu Pharma Recent Development
    Table 77. Teva Pharmaceutical Industries Ltd. Company Detail
    Table 78. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 79. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product
    Table 80. Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 81. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 82. Taiji group Company Detail
    Table 83. Taiji group Business Overview
    Table 84. Taiji group Nausea And Vomiting Treatment Product
    Table 85. Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 86. Taiji group Recent Development
    Table 87. Novartis Company Detail
    Table 88. Novartis Business Overview
    Table 89. Novartis Nausea And Vomiting Treatment Product
    Table 90. Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 91. Novartis Recent Development
    Table 92. Heron Therapeutics Company Detail
    Table 93. Heron Therapeutics Business Overview
    Table 94. Heron Therapeutics Nausea And Vomiting Treatment Product
    Table 95. Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 96. Heron Therapeutics Recent Development
    Table 97. Pharmanovia Company Detail
    Table 98. Pharmanovia Business Overview
    Table 99. Pharmanovia Nausea And Vomiting Treatment Product
    Table 100. Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 101. Pharmanovia Recent Development
    Table 102. Mylan Company Detail
    Table 103. Mylan Business Overview
    Table 104. Mylan Nausea And Vomiting Treatment Product
    Table 105. Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 106. Mylan Recent Development
    Table 107. Duchesnay Company Detail
    Table 108. Duchesnay Business Overview
    Table 109. Duchesnay Nausea And Vomiting Treatment Product
    Table 110. Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 111. Duchesnay Recent Development
    Table 112. GSK Company Detail
    Table 113. GSK Business Overview
    Table 114. GSK Nausea And Vomiting Treatment Product
    Table 115. GSK Revenue in Nausea And Vomiting Treatment Business (2019-2024) & (US$ Million)
    Table 116. GSK Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nausea And Vomiting Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Nausea And Vomiting Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Serotonin Receptor Antagonist Features
    Figure 4. Neurokinin NK1 Receptor Antagonist Features
    Figure 5. Others Features
    Figure 6. Global Nausea And Vomiting Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Nausea And Vomiting Treatment Market Share by Application: 2023 VS 2030
    Figure 8. CINV Case Studies
    Figure 9. PONV Case Studies
    Figure 10. Motion Sickness Case Studies
    Figure 11. Pregnancy Case Studies
    Figure 12. Others Case Studies
    Figure 13. Nausea And Vomiting Treatment Report Years Considered
    Figure 14. Global Nausea And Vomiting Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Nausea And Vomiting Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Nausea And Vomiting Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Nausea And Vomiting Treatment Market Share by Players in 2023
    Figure 18. Global Top Nausea And Vomiting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Nausea And Vomiting Treatment Revenue in 2023
    Figure 20. North America Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 22. United States Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 26. Germany Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2019-2030)
    Figure 34. China Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 42. Mexico Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2019-2030)
    Figure 46. Turkey Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Nausea And Vomiting Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Merck & Co. Inc. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 49. Helsinn Group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 50. Unimed Pharmaceuticals (AbbVie Inc.) Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 51. Kyowa Kirin Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 52. Sanofi Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 53. Qilu Pharma Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 55. Taiji group Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 56. Novartis Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 57. Heron Therapeutics Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 58. Pharmanovia Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 59. Mylan Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 60. Duchesnay Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 61. GSK Revenue Growth Rate in Nausea And Vomiting Treatment Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS